Periscope Capital’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Periscope Capital’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-165,031	Closed	-$1.65M	–	972
2022 Q3	$1.65M	Buy	165,031 +12,264	+8%	+$122K	0.05%	528
2022 Q2	$1.51M	Hold	152,767	–	–	0.04%	569
2022 Q1	$1.5M	Buy	152,767 +2,967	+2%	+$29.1K	0.04%	587
2021 Q4	$1.46M	Sell	149,800 -200	-0.1%	-$1.96K	0.04%	558
2021 Q3	$1.47M	Hold	150,000	–	–	0.04%	531
2021 Q2	$1.45M	Hold	150,000	–	–	0.05%	488
2021 Q1	$1.45M	Buy	+150,000	New	+$1.46M	0.06%	394

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Periscope Capital's PKBO Position: Q4 2022 in Review

Periscope Capital sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 165,031 shares — an estimated $1.65M sold.

Periscope Capital first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $1.65M in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Periscope Capital reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Periscope Capital sold 165,031 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $1.65M.
Periscope Capital first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Periscope Capital's Peak Bio, Inc. Common Stock position peaked at $1.65M in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Periscope Capital's 13F filing for Q4 2022, filed 13 Feb 2023.